• Combination Therapy

    Regenetek’s Combination Stem Cell and Vascular Therapy

    read more
  • Regenerative Medicine

    ‎The Most Current Information Available from Leading Scientists and Clinical Trials World-wide

    read more
  • Patient Registry Software

    Application of Technology to Make Any Size of Study Self-Managing and Affordable

    read more
  • Neurodegenerative Disorders

    The Latest Updates on Diseases Treatable Through Regenerative Medicine

    read more
  • Topical Commentary

    Opinions from Regenetek and Leading Authorities in Regenerative Medicine

    read more

Introductory word

Hundreds of thousands of undocumented therapies occur in clinics world-wide each year under the label of ‘medical tourism’. Even if physicians in these clinics wanted to follow their patients, there has been no method of doing so. Until now. Regenetek Research recognizes that there is a high need for a method and a study design that provides proof of both safety and efficacy for new treatment interventions such as autologous stem cell therapies or unsanctioned vascular surgeries. These types of medical interventions present viable choices for patients beyond conventional drug therapies that only treat symptoms.


Deb O’Connell (click to watch)

MS Patient Under Study

Dr. Doug Broeska, PHD

Medical Researcher, Author

Risk Factors and Potential Causes of MS*** The UNUSUAL Suspects

Someone asked me the other day what exactly causes the neurotoxic leakage of fibrinogen across the blood brain barrier in the MS central nervous system leading to lesions in the brain and subsequent neurologic symptoms. They meant, WHY are these vessels in the MS brain so prone to injury? If you’ve been reading my blogs here, you know that I’ve been heavily promoting that this leakage of fluids sets off the cascade of events that incites an immune response in the brain (CNS) and subsequent inflammation. This is where the research is taking us (although neurologists do not generally know of this research because it’s in the area of vascular medicine). We can also turn that question around to ask why that same type of injury and subsequent leakage doesn’t occur in the vast majority of the population. The Davalos UCSF study (among other studies) has shown that this leakage is most certainly ‘the cause’ of MS in those patients who are predisposed to disease development. We have seen thinner walled veins and strange valvular anomalies in most if not all MS patients. Zamboni based his hypothesis around weakened jugular veins but didn’t carry his observations, nor his treatment far enough. He had to look further upstream to find the real problem. So what is really going on here that is causing these venous lesions in the MS brain?